← Leaderboards
Terry Goldberg
Feinstein Institute For Medical Research
$10,595,465
Attributed
$17,151,278
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,151,278 · 6
By mechanism
R01$11,308,916 · 2
P50$4,124,256 · 2
U19$1,718,106 · 2
Top collaborators
- Philip D. Harvey7 shared
- Lon S Schneider7 shared
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Christoph U Correll$3,918,408
- Serge Sevy$1,998,778
- Vincent Robert Bonagura$5,873,561
- Debra C Rand$418,500
- Todd Lencz$13,113,988
Others in their field
Top investigators on “Cognition”
- David R. Weir · University Of Michigan At Ann Arbor$380,402,429
- Paul S. Aisen · Cognition Therapeutics, Inc.$185,453,129
- Randall J Bateman · Washington University$179,917,643
- Reisa A. Sperling · Banner Health$160,454,465
- Michael W Weiner · Northern California Institute Res &Educ$153,571,751
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,618,221
Research focus
CognitionAlzheimer&AposSchizophreniaPerformanceBaseResponseMagnetic Resonance ImagingDesignStructureNeurosciences ResearchGenerationsFunctional OutcomesAntipsychotic AgentsCognitiveNeurocognitiveNeuropsychologicalCognitive NeuroscienceRandomizedBiological MarkersGenotypeInnovationImpaired CognitionBehavioralFirst Episode Schizophrenia
Grant awards (31)
Cognitive Assessment and Adjudication Core$335,934
U19 · FY2025 · AG · contact PI
Cognitive Assessment and Adjudication Core$456,147
U19 · FY2024 · AG · contact PI
Cognitive Assessment and Adjudication Core$445,107
U19 · FY2023 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$2,109,311
R01 · FY2022 · AG · contact PI
Cognitive Assessment and Adjudication Core$480,918
U19 · FY2022 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$2,080,252
R01 · FY2021 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$1,505,130
R01 · FY2020 · AG · contact PI
Novel Cognitive and Functional Measures for Alzheimer's Disease Prevention Trials: Sensitivity to Biomarkers$637,919
R01 · FY2020 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$400,184
R01 · FY2020 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$1,505,129
R01 · FY2019 · AG · contact PI
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials$1,595,795
R01 · FY2018 · AG · contact PI
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment$263,337
R01 · FY2015 · AG · contact PI
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment$270,874
R01 · FY2014 · AG · contact PI
BDNF val66met Genotype and Age: Hurricane Sandy Supplement$146,238
R01 · FY2014 · AG · contact PI
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment$256,023
R01 · FY2013 · AG · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$519,054
P50 · FY2012 · MH · contact PI
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment$268,500
R01 · FY2012 · AG · contact PI
Research Methods Core: Cognitive Neuroscience$258,456
P50 · FY2012 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$79,081
P50 · FY2012 · MH · contact PI
Research Methods Core: Cognitive Neuroscience$79,079
P50 · FY2012 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$36,582
P50 · FY2012 · MH · contact PI
Research Methods Core: Cognitive Neuroscience$36,581
P50 · FY2012 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$515,246
P50 · FY2011 · MH · contact PI
BDNF val66met Genotype and Age: Impact on Biomarkers and Exercise-based Treatment$270,224
R01 · FY2011 · AG · contact PI
Research Methods Core: Cognitive Neuroscience$262,966
P50 · FY2011 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$522,632
P50 · FY2010 · MH · contact PI
Research Methods Core: Cognitive Neuroscience$265,928
P50 · FY2010 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$519,580
P50 · FY2009 · MH · contact PI
Research Methods Core: Cognitive Neuroscience$263,557
P50 · FY2009 · MH · contact PI
Neurocognitive function and treatment response in first episode schizophrenia$507,096
P50 · FY2008 · MH · contact PI
Research Methods Core: Cognitive Neuroscience$258,418
P50 · FY2008 · MH · contact PI